Publications by authors named "R A Kaye"

Claim this Profile
A
Artificial Intelligence Models for Dysphonia Patient Education.
Rebecca An Ho, Esha Shah, John Sebastian De Armas, Kenneth Yan, Rachel Kaye

Otolaryngol Head Neck Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the epidemiological and economic impact of the ADLIFE intervention on medium- to long-term in patients with advanced chronic disease.
Igor Larrañaga, Javier Mar, Ania Gorostiza, Borja García-Lorenzo, Beñat Zubeltzu, Rachelle Kaye

Front Public Health· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bexicaserin for the treatment of seizures in developmental and epileptic encephalopathies: A phase 1b/2a trial (PACIFIC).
Dennis J Dlugos, Ingrid E Scheffer, Jacqueline A French, David G Vossler, Chad Orevillo, Randall Kaye

Epilepsia· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses and Dose Titration of Bexicaserin in Healthy Participants in a Randomized, Double-Blind, Placebo-Controlled Study.
Jonathan Williams, Rosa Chan, Chad Orevillo, Gale O'Connell, Dewey McLin, Randall Kaye

Clin Pharmacol Drug Dev· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Bexicaserin in Healthy Participants: A First-in-Human Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Escalation Phase 1 Study.
Rosa Chan, Chad Orevillo, Gale O'Connell, Dewey McLin, Shikha Polega, Randall Kaye

Clin Pharmacol Drug Dev· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis